Delivery Order SPE2DB22D1200-SPE2DB25FN3DJ
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,666.37 firm fixed price delivery order for 1,440 units of HAVRIX 1,440 Unit/mL syringe on April 18, 2025, with ultimate completion scheduled for April 21, 2025. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office, with performance to occur at the company's Conshohocken, Pennsylvania headquarters. HAVRIX is a hepatitis A vaccine commonly utilized by the Department of Defense for...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.85 to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 UNIT/ML in syringe format. This competitively awarded, firm fixed-price contract was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly utilized by military and federal healthcare systems for...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix (hepatitis A vaccine) in single-dose syringes, valued at $2,286.70 with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded a delivery order valued at $11,651.70 to AmerisourceBergen Drug Corp for the supply of HAVRIX 720 Unit/0.5 ML syringes, with an ultimate completion date of September 15, 2025. This firm fixed-price contract, awarded on September 12, 2025, represents a non-competitive set-aside delivery and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly utilized across military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,613.80 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 4, 2025, and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the location of performance for this delivery order, which falls under the company's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,991.25 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 mL syringes on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a delivery order valued at $9,508.18 to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine in syringe form. This competitively awarded, firm fixed-price delivery order was finalized on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...